BioHarvest Sciences (BHST) Announces Strategic CDMO Agreement With Saffron Tech

BioHarvest Sciences Inc. (NASDAQ:BHST) is one of the best consumer defensive stocks with more than 50% upside. On October 30, BioHarvest Sciences Inc. (NASDAQ:BHST) announced a strategic CDMO agreement with Saffron Tech for the development and commercialization of saffron-derived botanical compounds by employing BioHarvest’s patented Botanical Synthesis platform, which allows “consistent, scalable, and cost-effective production of plant-based molecules without growing the plant itself”. Saffron Tech pioneers “advanced cultivation methods” for saffron, which is one of the most valued and health-promoting botanicals in the world.

Is Helen of Troy Limited (HELE) the Ridiculously Cheap Stock to Invest in?

According to the terms of the agreement, 75% of the developed saffron compositions, ownership IP, and commercial associated rights would be owned by Saffron Tech, while the remaining 25% will be held by BioHarvest Sciences Inc. (NASDAQ:BHST).

BioHarvest Sciences Inc. (NASDAQ:BHST) also announced that it aims to manufacture the compound at large scale upon the completion of the composition’s development phases, while also marketing it in its direct-to-consumer e-commerce business through the development of “a line of nutraceutical products leveraging saffron’s functional benefits”, including eye health, cognitive functions, and antioxidant benefits.

BioHarvest Sciences Inc. (NASDAQ:BHST) offers nutraceutical health and wellness products, including dietary supplements.

READ NEXT: 30 Stocks That Should Double in 3 Years and 11 Hidden AI Stocks to Buy Right Now.

Disclosure: None. This article is originally published at Insider Monkey.